Prescription drug · ANDA
Milnacipran Hydrochloride NDC 31722-880
Kit · Camber Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 31722-880-31 | 31722088031 | 1 KIT in 1 BLISTER PACK (31722-880-31)Marketed from Mar 19, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Milnacipran Hydrochloride
- Generic name (nonproprietary)
- milnacipran hydrochloride
- Dosage form
- Kit
- Labeler
- Camber Pharmaceuticals, Inc.NDC labeler code 31722
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205147
- Marketing start
- Listing expires
- Identifiers
- Product ID 31722-880_4cbf720f-9cdf-7cfe-e063-6394a90a6d84SPL ID 4cbf720f-9cdf-7cfe-e063-6394a90a6d84SPL set ID 99efa59a-8458-4e04-8cb1-20abfc179228RxCUI 833135, 833141, 833144, 833147, 833150UNII RNZ43O5WW5UPC 0331722846608, 0331722847605, 0331722849609, 0331722848602
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N431722088031followed by a unit qualifier and the quantityPackage 31722-0880-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Milnacipran hydrochloride tablets are indicated for the management of fibromyalgia. Milnacipran hydrochloride tablets are not approved for use in pediatric patients [see Use in Specific Populations (8.4)] . Milnacipran hydrochloride tablets are a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the management of fibromyalgia (1) . Milnacipran hydrochloride tablets are not approved for use in pediatric patients (1) .
Excerpt only. Read the full label for complete information.
About NDC 31722-880
- What is NDC 31722-880?
- 31722-880 is the product NDC for Milnacipran Hydrochloride kit, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Milnacipran Hydrochloride.
- Who is the labeler?
- Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Milnacipran Hydrochloride?
- 16 other product NDCs are listed under this name. See all Milnacipran Hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Milnacipran Hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Milnacipran Hydrochloride | Milnacipran hydrochloride 12.5 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-369 | 33342-0369-0933342-0369-1233342-0369-15 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 25 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-370 | 33342-0370-0933342-0370-1233342-0370-15 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 50 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-371 | 33342-0371-0933342-0371-1233342-0371-15 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 100 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-372 | 33342-0372-0933342-0372-1233342-0372-15 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 12.5 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-846 | 31722-0846-3231722-0846-60 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 25 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-847 | 31722-0847-3231722-0847-60 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 50 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-848 | 31722-0848-3231722-0848-60 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 100 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-849 | 31722-0849-3231722-0849-60 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 12.5 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-034 | 51991-0034-06 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 50 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-036 | 51991-0036-06 |
Other NDCs under ANDA 205147
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Milnacipran Hydrochloride | Milnacipran hydrochloride 12.5 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-846 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 25 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-847 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 50 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-848 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 100 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-849 |